BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Suri J, Borja S, Lim JK. Combination strategies for pharmacologic treatment of non-alcoholic steatohepatitis. World J Gastroenterol 2022; 28(35): 5129-5140 [PMID: 36188726 DOI: 10.3748/wjg.v28.i35.5129]
URL: https://www.wjgnet.com/1007-9327/full/v28/i35/5129.htm
Number Citing Articles
1
Hsin-Tien Ho, Yu-Lueng Shih, Tien-Yu Huang, Wen-Hui Fang, Chang-Hsien Liu, Jung-Chun Lin, Chih-Weim Hsiang, Kai-Min Chu, Cheng-Huei Hsiong, Guan-Ju Chen, Yung-En Wu, Jia-Yu Hao, Chih-Wen Liang, Oliver Yoa-Pu Hu. Mixed active metabolites of the SNP-6 series of novel compounds mitigate metabolic dysfunction-associated steatohepatitis and fibrosis: promising results from pre-clinical and clinical trialsJournal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05686-7
2
Nurina Hasanatuludhhiyah, Arifa Mustika, Viskasari P. Kalanjati, Muhammad Miftahussurur, Naoto Uemura. Acetyl-CoA Carboxylase Inhibitors for Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPharmaceuticals 2025; 18(9): 1276 doi: 10.3390/ph18091276
3
Yibing Wang, Hanhan Yu, Zhipeng Cen, Yutong Zhu, Wenyi Wu. Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitisMetabolism Open 2024; 21: 100267 doi: 10.1016/j.metop.2023.100267
4
Tao Zhang, Yingli Nie, Jiliang Wang. The emerging significance of mitochondrial targeted strategies in NAFLD treatmentLife Sciences 2023; 329: 121943 doi: 10.1016/j.lfs.2023.121943
5
Yuval Ishay, Joel Neutel, Yotam Kolben, Ram Gelman, Orly Sneh Arbib, Oliver Lopez, Helena Katchman, Rizwana Mohseni, Miriam Kidron, Yaron Ilan. Oral Insulin Alleviates Liver Fibrosis and Reduces Liver Steatosis in Patients With Metabolic Dysfunction-associated Steatohepatitis and Type 2 Diabetes: Results of Phase II Randomized, Placebo-controlled Feasibility Clinical TrialGastro Hep Advances 2024; 3(3): 417 doi: 10.1016/j.gastha.2023.11.016
6
Yibing Wang, Jianan Zheng, Yun Long, Wenyi Wu, Yutong Zhu. Direct degradation and stabilization of proteins: New horizons in treatment of nonalcoholic steatohepatitisBiochemical Pharmacology 2024; 220: 115989 doi: 10.1016/j.bcp.2023.115989
7
Elisabetta Caon, Roberta Forlano, Benjamin H. Mullish, Pinelopi Manousou, Krista Rombouts. Sinusoidal Cells in Liver Diseases2024; : 513 doi: 10.1016/B978-0-323-95262-0.00025-5
8
Cailian FAN, Guan WANG, Miao CHEN, Yao LI, Xiyang TANG, Yi DAI. Therapeutic potential of alkaloid extract from Codonopsis Radix in alleviating hepatic lipid accumulation: insights into mitochondrial energy metabolism and endoplasmic reticulum stress regulation in NAFLD miceChinese Journal of Natural Medicines 2023; 21(6): 411 doi: 10.1016/S1875-5364(23)60403-0
9
Ralf Weiskirchen. Resmetirom and semaglutide in metabolic dysfunction-associated steatohepatitis (MASH): a comparative perspectiveExploration of Drug Science 2025; 3 doi: 10.37349/eds.2025.1008132
10
Muna Shakhshir, Sa'ed H Zyoud. Mapping global research trends: Nutrition associations with nonalcoholic fatty liver disease - a Scopus bibliometric analysisWorld Journal of Gastroenterology 2024; 30(24): 3106-3119 doi: 10.3748/wjg.v30.i24.3106